A brain AVM (arteriovenous malformation) is a tangle of abnormal blood vessels that creates a direct connection between arteries and veins in the brain, bypassing the tiny capillaries that normally slow blood flow and deliver oxygen to surrounding tissue. About 18 in 100,000 people in the U.S. have one, though only 1 in 100,000 are ever diagnosed, since many never cause symptoms.
How a Brain AVM Disrupts Blood Flow
In a healthy brain, arteries carry high-pressure blood into progressively smaller vessels until it reaches capillaries, where oxygen and nutrients pass into brain tissue. Blood then moves into veins at much lower pressure. An AVM skips the capillary step entirely. Instead, a cluster of abnormal, dilated channels called the “nidus” funnels blood straight from artery to vein. These channels are neither truly arterial nor venous. They’re structurally weaker than normal vessels.
This shortcut has two consequences. First, the brain tissue surrounding the AVM gets less oxygen because blood never passes through capillaries where the exchange happens. Second, the veins on the other side of the nidus receive blood at much higher pressure and flow than they were built to handle, which is what makes them prone to rupture.
Symptoms That May Signal an AVM
Many brain AVMs are discovered by accident during imaging for something else. When they do cause symptoms, the type depends on where in the brain the AVM sits.
- Seizures: The most common presenting symptom. These can be focal, affecting only one part of the body, or generalized, involving convulsions and loss of consciousness.
- Headaches: Variable in intensity and frequency, sometimes mimicking migraines. A headache that always occurs in the same spot on the head can hint at the AVM’s location.
- Vision problems: AVMs near the optic nerve or in the visual processing area at the back of the brain can cause partial vision loss or difficulty controlling eye movement.
- Muscle weakness or paralysis: Typically on one side of the body.
- Speech and language difficulty: Trouble speaking or understanding words.
- Coordination problems: AVMs in the brain stem or cerebellum can affect balance and walking.
- Numbness, tingling, or spontaneous pain.
- Cognitive changes: Difficulty planning, memory problems, confusion.
Some of these symptoms develop gradually as the AVM diverts blood from healthy tissue. Others appear suddenly if the AVM bleeds.
The Risk of Bleeding
Hemorrhage is the most dangerous complication of a brain AVM. An untreated AVM carries roughly a 2% to 4% annual risk of bleeding. That number sounds small in any given year, but it compounds over a lifetime. For someone diagnosed at age 30, the cumulative risk over decades is substantial.
Once an AVM bleeds for the first time, the risk of rebleeding climbs sharply. In one large study, the rebleeding rate was about 10% in the first year after the initial hemorrhage and remained elevated at 6% to 9% annually for years afterward. Patients who have bled twice face a 25% chance of bleeding again within a single year. This escalating risk is a major factor in treatment decisions.
Pregnancy and AVMs
Pregnancy increases the hemorrhage risk meaningfully. Research from a North American cohort found that the annual hemorrhage rate jumped from about 1.3% in non-pregnant patients to 7.0% during pregnancy in women of reproductive age, roughly a fivefold increase. All ruptures during pregnancy occurred in the second or third trimester. Two of the eight women who bled during pregnancy experienced a second bleed during the same pregnancy or shortly after delivery. CT scans can safely evaluate a pregnant patient for brain bleeding with abdominal shielding, and the gold standard diagnostic test (catheter angiography) delivers radiation to the fetus well below accepted safety limits.
How AVMs Are Diagnosed
MRI is often the first imaging to reveal an AVM, but the gold standard for diagnosis is digital subtraction angiography, a catheter-based procedure where dye is injected into the brain’s blood vessels while rapid X-ray images are taken. This technique provides superior spatial detail and, critically, shows the dynamic flow of blood through the AVM in real time. That temporal information lets doctors distinguish the nidus from the draining veins, which standard MRI or CT angiography cannot do as effectively because they capture only a single snapshot.
Once an AVM is confirmed, doctors grade it to estimate surgical risk. The most widely used system scores three factors: the size of the nidus, whether it sits in an area of the brain that controls critical functions like speech or movement, and whether it drains into deep veins (which are harder to access safely). The total score ranges from Grade I (smallest, safest to operate on) to Grade V (largest, highest surgical risk). This grading directly shapes which treatment approach is recommended.
Treatment Options
Treatment aims to eliminate the AVM entirely, since a partially treated AVM can still bleed. Three main approaches exist, and they’re often used in combination.
Microsurgery
Open surgery to physically remove the AVM is the most definitive treatment and the preferred option for lower-grade AVMs. The surgeon opens the skull, identifies the feeding arteries, disconnects them, and removes the nidus. Recovery typically involves at least six weeks off work, with most people returning to usual activities within four to six weeks but needing two to six months for full recovery. Strenuous exercise is generally off limits for two to four weeks, and heavy lifting is restricted for about three weeks.
Stereotactic Radiosurgery
For AVMs that are small or located in areas too risky for open surgery, focused radiation beams can be aimed at the nidus to trigger gradual scarring and closure. This is not traditional surgery. There’s no incision. The downside is time: the AVM doesn’t close immediately. At three years after treatment, about 33% of AVMs are fully closed. By five years, that number reaches roughly 56%. During this waiting period, the AVM can still bleed. Most radiation-related complications occur in the first three years, so extending the observation window to five years before considering retreatment generally improves outcomes.
Endovascular Embolization
In this catheter-based procedure, a thin tube is threaded from the groin up into the brain’s blood vessels. Once positioned at the AVM, the doctor injects a liquid glue-like substance that hardens inside the abnormal vessels, blocking blood flow. The two main agents used are a fast-setting surgical glue and a newer polymer that solidifies more slowly, giving the operator more control. Embolization alone reduces the AVM’s size by an average of about 75%, but complete closure from embolization alone is uncommon. It’s most often used to shrink an AVM before surgery or radiosurgery, reducing the risk of those procedures.
Living With an Untreated AVM
Not every AVM requires immediate intervention. Higher-grade AVMs, where the surgical risk may outweigh the bleeding risk, are sometimes managed conservatively with regular imaging and symptom monitoring. This is a calculated decision, not neglect. For these patients, understanding the annual bleeding risk and recognizing warning signs like sudden severe headache, new seizures, or abrupt neurological changes is essential. AVMs are present from birth and are not caused by anything a person did or didn’t do, though most are not inherited.